Combined administration of a 5-hydroxytryptamine (5-HT)(1D) antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 2204-2207

  Rollema, Hans ^a   Clarke, Thomas ^a   Sprouse, Jeffrey S ^a   Schulz, David W ^a  

^a PFIZER INC   (United States)

Author keywords

5 HT(1D) receptor antagonists; 5 Hydroxytryptamine; Antidepressant; Guinea pig hypothalamus; Microdialysis; Selective serotonin reuptake inhibitor; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AUTORECEPTOR; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 1D ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; DEPRESSION; HYPOTHALAMUS; MALE; MICRODIALYSIS; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0029823246     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67052204.x     Document Type: Article

References (22)

1. Artigas F., Pèrez V., and Alvarez E. (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51, 248-251.
2. Berman R. M., Darnell A. M., Miller H. L., Anand A., and Charney D. S. (1995) Randomized controlled trial of pindolol in treatment naive and treatment refractory depression. Soc. Neurosci. Abstr. 21, 977.
3. Blier P. and Bergeron R. (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15, 217-222.
4. Blier P. and De Montigny C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226.
5. Briley M. and Moret C. (1993) Neurobiological mechanisms involved in antidepressant therapies. Clin. Neuropharmacol. 16, 387-400.
6. Chaput Y., De Montigny C., and Blier P. (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 333, 342-348.
7. 1D antagonists. J. Med. Chem. 37, 2253-2257.
8. 1D autoreceptors. Br. J. Pharmacol. 114, 1107-1109.
9. 1D receptor subtypes. Trends Pharmacol. Sci. 17, 103-105.
10. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 60, 776-779.
11. Hoyer D. and Middlemiss D. N. (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci. 10, 130-132.
12. 1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behavior in the guineapig. Neuropharmacology 34, 383-392.
13. 1D receptor. J. Med. Chem. 37, 2509-2512.
14. 1D autoreceptors in human cerebral cortex. J. Neurochem. 60, 1179-1182.
15. 1D receptor antagonist, GR127935, on in vivo 5-HT release, synthesis and turnover in the guinea-pig frontal cortex. (Abstr.) Br. J. Pharmacol. 112, 489P.
16. 1D agonist CP-135,807 (Abstr.), in Monitoring Molecules in Neuroscience, Proceedings of the 6th International Conference on In Vivo Methods (Louillot A., Durkin T., Spampinato U., and Cador M., eds), pp. 199-200. Publi Typ, Gradignan, France.
17. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus as determined by brain microdialysis. Br. J. Pharmacol. 96, 283-290.
18. 1D receptor antagonist GR127935 on extracellular 5-HT levels in guinea-pig frontal cortex as measured by microdialysis. Neuropharmacology 34, 377-382.
19. Sleight A. J., Cervenka A., and Peroutka S. J. (1990) In vivo effects of sumatriptan (GR43175) on extracellular levels of 5-HT in the guinea pig. Neuropharmacology 29, 511-513.
20. 1D autoreceptors in 5-HT release. Soc. Neurosci. Abstr. 21, 1369.
21. 1A autoreceptors modulate 5-HT release in the guinea pig dorsal raphé nucleus. Neuropharmacology 33, 393-402.
22. 1D antagonist. Soc. Neurosci. Abstr. 20, 1543.